| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/01/2007 | CN1329394C Novel imidazole derivatives, production method thereof and use thereof |
| 08/01/2007 | CN1329393C New purine derivatives |
| 08/01/2007 | CN1329388C 1,3,5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 08/01/2007 | CN1329359C Ether compounds, compositions, and uses thereof |
| 08/01/2007 | CN1329083C Method for degrading AML 1-ETO fusion protein and used reagent |
| 08/01/2007 | CN1329082C Polymer conjugates of interferon beta-1a and their uses |
| 08/01/2007 | CN1329081C Method for preparing antineoplastic nanometer heat sensitive target medicine carrier |
| 08/01/2007 | CN1329080C Cachexia remedy |
| 08/01/2007 | CN1329044C Anti-tumor active matter and its preparing method and use |
| 08/01/2007 | CN1329039C Medicine for treating leukopenia and its preparing method |
| 08/01/2007 | CN1329038C Water soluble nightshade extract, its preparation method and pharmaceutical compositions |
| 08/01/2007 | CN1329030C Inhibitor for liver cancer onset and progress |
| 08/01/2007 | CN1329026C Pharmaceutical composition comprising (-)-secoisolariciresinol |
| 08/01/2007 | CN101010427A Anti-A33 antibody |
| 08/01/2007 | CN101010342A Compositions and methods for treatment of non-hodgkin's lymphoma |
| 08/01/2007 | CN101010337A Fas associated factor 1 |
| 08/01/2007 | CN101010319A Indole derivatives, their manufacture and use as pharmaceutical agents |
| 08/01/2007 | CN101010318A 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 08/01/2007 | CN101010317A 2, 4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 08/01/2007 | CN101010315A Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
| 08/01/2007 | CN101010304A Molecular chaperone function regulator |
| 08/01/2007 | CN101010303A Quinazolinone derivatives and their use as B-RAF inhibitors |
| 08/01/2007 | CN101010106A Conjugates of antibody and Duocarmycin derivatives as antitumor agents |
| 08/01/2007 | CN101010103A Camptothecin derivatives conjugated in position 20 with integrin antagonists. |
| 08/01/2007 | CN101010102A Composition comprising non-oxidizable fatty acid analogoues and plant and/or fish oils |
| 08/01/2007 | CN101010101A Composition comprising protein material and non-oxidizable fatty acid entities |
| 08/01/2007 | CN101010097A Hai-1 and hai-2 in cancer therapy |
| 08/01/2007 | CN101010093A Method of improving anticancer effect of pulsatillae radix and composition prepared by the method |
| 08/01/2007 | CN101010082A Use of midostaurin for treating gastrointestinal stromal tumors |
| 08/01/2007 | CN101007992A Health white spirit containing beneficial functional component |
| 08/01/2007 | CN101007851A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
| 08/01/2007 | CN101007850A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
| 08/01/2007 | CN101007849A Low molecule agonist antibodies |
| 08/01/2007 | CN101007846A T8 synthetic product and application thereof |
| 08/01/2007 | CN101007844A Synthetic peptides and methods for treating cancer invasion and metastasis |
| 08/01/2007 | CN101007842A T4 synthetic product and application thereof |
| 08/01/2007 | CN101007839A Nucleic acid molecule RTN4BSR12 and its application in preparing anticancer medicine |
| 08/01/2007 | CN101007838A Nucleic acid molecule RTN4BSR22 and its application in preparing anticancer medicine |
| 08/01/2007 | CN101007837A Nucleic acid molecule RTN4BSR42 and its application in preparing anticancer medicine |
| 08/01/2007 | CN101007836A Nucleic acid molecule RTN4BSR52 and its application in preparing anticancer medicine |
| 08/01/2007 | CN101007835A Nucleic acid molecule RTN4BSR5 and its application in preparing anticancer medicine |
| 08/01/2007 | CN101007834A Nucleic acid molecule RTN4BSR4 and its application in preparing anticancer medicine |
| 08/01/2007 | CN101007833A Nucleic acid molecule RTN4BSR3 and its application in preparing anticancer medicine |
| 08/01/2007 | CN101007832A Nucleic acid molecule RTN4BSR2 and its application in preparing anticancer medicine |
| 08/01/2007 | CN101007831A Nucleic acid molecule RTN4BSR1and its application in preparing anticancer medicine |
| 08/01/2007 | CN101007815A Pyrrolehexa-heterocyclic compound and pharmaceutical use thereof |
| 08/01/2007 | CN101007814A Pyrrolehexa-heterocyclic compound and pharmaceutical use thereof |
| 08/01/2007 | CN101007809A Water-soluble camptothecine derivative and its preparation process and application thereof |
| 08/01/2007 | CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/01/2007 | CN101007801A Pyrrole substituted 2-dihydromolindone derivative, its preparation method and medical uses |
| 08/01/2007 | CN101007796A Quinary-heterocyclic compound, its preparation method and medical uses |
| 08/01/2007 | CN101007175A Alpha and beta poly (L asparamide) amino acid derivatives cisplatin macromolecule prodrug, preparation method and use thereof |
| 08/01/2007 | CN101007174A Biodegradable polymer docetaxel bonded drug and preparation method thereof |
| 08/01/2007 | CN101007173A Anti-angiogene compositions and methods of use |
| 08/01/2007 | CN101007161A Mixture of naja naja actra venom and Chinese herbal medicine extracts and application thereof |
| 08/01/2007 | CN101007159A Traditional Chinese medicine for preventing and controlling tumor |
| 08/01/2007 | CN101007158A A traditional Chinese medicine composition for treating malignant tumors |
| 08/01/2007 | CN101007134A Oral medicine for treating breast cancer |
| 08/01/2007 | CN101007131A A natural anticancer capsule |
| 08/01/2007 | CN101007129A A traditional Chinese medicine for treating leukemia |
| 08/01/2007 | CN101007114A An adjuvant drug or health food for tumor patients and preparation thereof |
| 08/01/2007 | CN101007110A An antitumor medicine and its preparation method |
| 08/01/2007 | CN101007056A An antitumor medicinal composition and its preparation method |
| 08/01/2007 | CN101007055A Preparation method of pollen of eucommia ulmoides soft capsules containing alpha-linolenic acid |
| 08/01/2007 | CN101007052A An antitumor medicine and its preparation method |
| 08/01/2007 | CN101007050A Extract of an traditional Chinese medicine containing isopsoralen, preparation method and use thereof |
| 08/01/2007 | CN101007047A An antitumor medicine composition and its preparation method |
| 08/01/2007 | CN101007037A Total triterpenes of solidago canadensis extracts, preparation method and use thereof |
| 08/01/2007 | CN101007034A Extraction technology of alkaloids from fresh catharanthus roseus |
| 08/01/2007 | CN101007033A Extraction technology of alkaloids from fresh catharanthus roseus |
| 08/01/2007 | CN101007026A An anticancer medicinal composition, preparing method and use thereof |
| 08/01/2007 | CN101007001A Therapeutic methods and compositions involving isoflavones |
| 08/01/2007 | CN101007000A Therapeutic methods and compositions involving isoflavones |
| 08/01/2007 | CN101006999A Therapeutic methods and compositions involving isoflavones |
| 08/01/2007 | CN101006998A Taxol drug supported by polymer nanoparticles and its preparation method |
| 08/01/2007 | CN101006997A Compound taxol and its derivative docetaxel fat emulsion and preparation method |
| 08/01/2007 | CN101006984A An injection preparation containing salvianolic acid A and extract of panax natoginseng, and its preparation method and application |
| 08/01/2007 | CN101006982A Anticancer medicine composition of taxane and its synergist |
| 08/01/2007 | CN101006981A Slow released injection containing taxane and platinum |
| 08/01/2007 | CN101006980A Anticancer composition containing taxane and alkaloids |
| 08/01/2007 | CN101006979A Anticancer composition containing taxane and topoenzyme inhibitor |
| 08/01/2007 | CN101006978A Anticancer medicinal composition containing taxane and alkylating agents |
| 08/01/2007 | CN101006977A Anticancer medicinal composition containing taxane and hormones drug |
| 08/01/2007 | CN101006976A Anticancer medicinal composition of loaded taxane and its synergist |
| 08/01/2007 | CN101006975A An oral medicine preparation containing salvianolic acid A and extract of panax natoginseng, and its preparation method and application |
| 08/01/2007 | CN101006860A Smoke-roasting bamboo salt and its making method |
| 08/01/2007 | CN101006844A Seabuckthorn germ rice having antitumour function and its preparation method |
| 07/31/2007 | US7250531 Process for the synthesis and crystalline form of agomelatine |
| 07/31/2007 | US7250516 Phenylalanine derivatives |
| 07/31/2007 | US7250492 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 07/31/2007 | US7250430 Administering N-benzoyl- derivatives, e.g., N-[2,4-dichlorobenzoyl]-5-bromothiophene-2-sulfonamide sodium salt, to treat metastatic soft tissue sarcoma, non-small cell lung cancer, melanoma, ovarian cancer, breast cancer, leukemia, lymphoma, renal cancer, prostate cancer, and multiple myeloma |
| 07/31/2007 | US7250416 Alkyl, substituted or unsubstituted ribose, or 2'-deoxyribose substituted 1,3,5-triazin-2(1H)-ones, which may be additionally substituted with alkyl, aryl, halo, amino, oxy, thio, and/or hydrazine groups; used for treating diseases such as hematological disorders and cancer |
| 07/31/2007 | US7250409 Ningalin B analogs employable for reversing multidrug resistance |
| 07/31/2007 | US7250403 Administration of immunomodulatory polynucleotide microcarrier complexes featuring a polynucleotide comprising at least one immunostimulatory sequence bound to a biodegradable microcarrier or noncarrier |
| 07/31/2007 | US7250400 Can be used for developing a study of cell attachment activity mediated through various extracellular matrix protein containing beta ig-h3, wound healing, tissue regeneration and metastasis inhibition. |
| 07/31/2007 | US7250395 Antagonist peptides to VEGF receptor Flt-1 |
| 07/31/2007 | US7250394 Blocking glutamate function at an ionotropic glutamate receptor. e.g., N-methyl-D-aspartate receptor, the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid receptor and the kainate receptor; brain disorders; spinal chord |
| 07/31/2007 | US7250283 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease |
| 07/31/2007 | US7250275 LIF has a differentiation prevention function for a chicken differentiable cell such as a chicken's embryonic stem cell or embryonic reproductive cell, effective as an anti-differentiator while the chicken differentiable cell is being cultured |
| 07/31/2007 | US7250272 Signal transduction membrane protein for diagnosis, prevention and treatment of central nervous system, endocrine, metabolic and cancer |